… antibodies (mAbs) is a promising therapeutic approach for Ebola virus disease (EVD).
However, all mAbs and mAb cocktails … , a cocktail of two broadly neutralizing human mAbs, ADI-…

… cocktail against SARS-CoV-2. On the basis of our previously identified humanized cross-neutralizing
antibody H014, we systematically analyzed a fully human naive antibody library …

… antibodies, and places an emphasis on antibody cocktails that seek to mimic the potency of
natural polyclonal-antibody … human antibodies, and pooled sera might be used to prepare …

… In this ongoing, double-blind, phase 1–3 trial involving nonhospitalized patients with
Covid-19, we investigated two fully human, neutralizing monoclonal antibodies against severe …

… antibody cocktail therapeutics for Ebola were generated by mixing NAbs from humanized
antibodies from mice and human … critical roles in the design of antibody cocktails, and that this …

… monoclonal antibody cocktail CL184 against rabies. … human monoclonal antibody (mAb)
cocktail, CL184, which consists of two mAbs (CR57, human IgG1 lambda and CR4098, human …

… Inclusion of such antibodies into an antibody cocktail … an antibody-based therapeutic for
treatment and prevention of COVID-19. Such an antibody cocktail is now being tested in human …

… , individually as well as when combined into cocktails. These antibodies remain effective
against spike variants that have arisen in the human population. However, novel spike mutants …

… antibody (mAb) cocktails are poorly defined. Here, we exploited antibody cooperativity to
develop a therapeutic mAb cocktail … analyzed the antibody repertoire in human survivors and …

… used to guide development of a cocktail of human monoclonal antibodies as a replacement
for RIG. … Therefore, we conclude that the human mAb cocktail CR57/CR4098 is a safe and …